Cargando…

Evaluation of the Effects of Atorvastatin on the Treatment of Secondary Pulmonary Hypertension due to Chronic Obstructive Pulmonary Diseases: A Randomized Controlled Trial

BACKGROUND: Since pulmonary hypertension (PH) in patients with chronic obstructive pulmonary diseases (COPD) causes poor prognosis and inflammatory process involved in PH, it is supposed that Statins with anti-inflammatory effects might be useful in the treatment of PH. OBJECTIVES: The aim of this s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moosavi, Seyed Ali Javad, Raji, Hanieh, Faghankhani, Masoomeh, Yazdani, Rostam, Esmaeili, Mansour
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3918187/ https://www.ncbi.nlm.nih.gov/pubmed/24578830 http://dx.doi.org/10.5812/ircmj.8267

Ejemplares similares

Effect of Zafirlukast on improving lung function in patients with chronic obstructive pulmonary diseases
por: Moosavi, Seyed Ali Javad, et al.
Publicado: (2013)

Overuse and underuse of pulmonary CT angiography in patients with suspected pulmonary embolism
por: Raji, Hanieh, et al.
Publicado: (2018)

Diagnostic sensitivity of impulse oscillometry in early detection of patients exposed to risk factors chronic obstructive pulmonary diseases
por: Mousavi, Seyed Ali Javad, et al.
Publicado: (2021)

The Effects and Mechanism of Atorvastatin on Pulmonary Hypertension Due to Left Heart Disease
por: Wang, Qing, et al.
Publicado: (2016)

The Effects of Vitamin D Supplementation on Pulmonary Function of Chronic Obstructive Pulmonary Disease Patients, before and after Clinical Trial
por: Moosavi, Seyed Ali Javad, et al.
Publicado: (2015)

Adiponectin Level in Serum and BAL Sample of Patients with Chronic Obstructive Pulmonary Disease
por: Yazdani, Rostam, et al.
Publicado: (2013)

Clinical evaluation of nebulized verapamil in out‐patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease
por: Fahimi, Fanak, et al.
Publicado: (2022)

Association of Bile Acid and Pepsin Micro-aspiration with Chronic Obstructive Pulmonary Disease Exacerbation
por: Hashemi-Bajgani, Seyed-Mehdi, et al.
Publicado: (2019)

Influence of atorvastatin on metabolic pattern of rats with pulmonary hypertension
por: Luo, Li, et al.
Publicado: (2021)

The Regulation of Pulmonary Vascular Tone by Neuropeptides and the Implications for Pulmonary Hypertension
por: Lo, Charmaine C. W., et al.
Publicado: (2018)

Helicobacter Pylori in Patients Suffering from Pulmonary Disease
por: Shams-Hosseini, Narges-ol-Sadat, et al.
Publicado: (2011)

Detection of Helicobacter Pylori in Bronchoalveolar Lavage of Patients With Chronic Obstructive Pulmonary Disease by Real Time Polymerase Chain Reaction
por: Samareh Fekri, Mitra, et al.
Publicado: (2014)

Relationship between serum procalcitonin level and chronic obstructive pulmonary disease
por: Borsi, Hamid, et al.
Publicado: (2019)

Secondary pulmonary hypertension due to pulmonary Langerhans cell histiocytosis accompanied with panhypopituitarism
por: Miyashita, Tatsuyuki, et al.
Publicado: (2020)

Use of Tadalafil for Treating Pulmonary Arterial Hypertension Secondary to Chronic Obstructive Pulmonary Disease
por: Kim, Hyun-Sook, et al.
Publicado: (2007)

Tongxinluo enhances the effect of atorvastatin on the treatment of atherosclerosis with chronic obstructive pulmonary disease by maintaining the pulmonary microvascular barrier
por: Kuang, Xiangnan, et al.
Publicado: (2022)

The effects of atorvastatin on mustard-gas-exposed patients with chronic obstructive pulmonary disease: A randomized controlled trial
por: Ghobadi, Hassan, et al.
Publicado: (2014)

Screening for pulmonary hypertension secondary to pulmonary tuberculosis
por: Raine, Richard
Publicado: (2020)

Effect of Aerobic Exercises on Serum Levels of Apolipoprotein A1 and Apolipoprotein B, and Their Ratio in Patients with Chronic Obstructive Pulmonary Disease
por: Yazdani, Rostam, et al.
Publicado: (2018)

Red Blood Cell Distribution Width Predicts Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
por: Yang, Jie, et al.
Publicado: (2019)

Evaluation of Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease
por: Aurangabadkar, Gaurang M, et al.
Publicado: (2022)

Pulmonary Hypertension Secondary to COPD
por: Shujaat, Adil, et al.
Publicado: (2012)

Unilateral Pulmonary Artery Agenesis in an Adult Patient with Cough and Hemoptysis: A Case Report
por: Moosavi, Seyed Ali Javad, et al.
Publicado: (2014)

Bosentan for pulmonary hypertension secondary to idiopathic pulmonary fibrosis
por: Onda, Naomi, et al.
Publicado: (2014)

Air pollution and hospital admissions due to deep vein thrombosis (DVT) in Ahvaz, Iran
por: Borsi, Seyed Hamid, et al.
Publicado: (2020)

To Compare PubMed Clinical Queries and UpToDate in Teaching Information Mastery to Clinical Residents: A Crossover Randomized Controlled Trial
por: Sayyah Ensan, Ladan, et al.
Publicado: (2011)

Obstruction of the Pulmonary Artery Due to Carcinoma
por: Harrington, Archibald W.
Publicado: (1913)

Pulmonary function tests in patients with amyotrophic lateral sclerosis and the association between these tests and survival
por: Javad Mousavi, Seyed-Ali, et al.
Publicado: (2014)

Update on pulmonary hypertension complicating chronic obstructive pulmonary disease
por: Jyothula, Soma, et al.
Publicado: (2009)

Pulmonary hypertension due to obstructive sleep apnea in a child with Rubinstein-Taybi syndrome
por: Choi, Hyung Soon, et al.
Publicado: (2012)

Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease
por: Sun, Wan-Lu, et al.
Publicado: (2019)

Pulmonary Hypertension and Hypocholesterolemia Secondary to Thyrotoxicosis
por: Shyamali, Narangoda Liyanage Ajantha, et al.
Publicado: (2020)

Comparison of the Serum Concentration of Zinc in Patients With Bronchiectasis and Control Group
por: JavadMoosavi, Seyed Ali, et al.
Publicado: (2013)

Pulmonary Artery Vasoconstriction Due to Bronchial Obstruction
por: Saliba, Thomas, et al.
Publicado: (2022)

Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease
por: Morrell, Nicholas W, et al.
Publicado: (2005)

Mechanisms of development of chronic obstructive pulmonary disease-associated pulmonary hypertension
por: Barberà, Joan Albert
Publicado: (2013)

Statins for the Treatment of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease
por: Chen, Chung-Yu, et al.
Publicado: (2021)

The role of vitamin D in chronic obstructive pulmonary disease with pulmonary hypertension
por: Li, Mengxi
Publicado: (2023)

Hypoxic Pulmonary Vasoconstriction and the Diffusing Capacity in Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis
por: Sakao, Seiichiro, et al.
Publicado: (2019)

A prospective, randomized study: Evaluation of the effect of rosuvastatin in patients with chronic obstructive pulmonary disease and pulmonary hypertension
por: Chogtu, Bharti, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_crv6slft3mdbr630mj18gaq0r5